CHRISTINA LILLYWHITE: Open Payments
NPI 1295467181 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 20 payments from 9 companies in 2025. Trend: 2023 $863 · 2024 $612 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Phathom Pharmaceuticals, Inc. | 5 | $90 |
| Ardelyx, Inc. | 2 | $32 |
| Gilead Sciences, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
| VIVUS LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: REZDIFFRA, ENTYVIO, VOQUEZNA, IBSRELA, CREON, TREMFYA, PANCREAZE, XELJANZ.
Industry payments across CT — which companies pay providers there.
